The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

The government agency says X no longer suits its communication needs.

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

GUANGZHOU, China I 7, 2025 I Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...

Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...